It's now officially Sunday which means you have time before Monday's bell. Though, before we do that, I need to bring to your attention what


Your New Profile For Monday (CPMD) Displays Breakout Potential Based On Short-term Technicals And More

Based On Short-term Technical Indicators And News Catalysts, (CPMD) Requires Your Immediate Attention

Friday's 9:30AM Profile Soars Approximately 66% Intraday!

August 9th

Good Evening,

It's now officially Sunday which means you have time before Monday's bell. Though, before we move forward, I need to bring to your attention what Friday's 9:30AM profile did.

Opening at $.0265, it blazed a path to a high of $.044 for an approximate 66% intraday run!

Now it's time to turn our attention to what's next...

Canna*bis ("CB") related stocks are well below their all-time highs, although many have experienced a bounce along with the recent market recovery.

The LGL MJ industry is still in its early stages and has experienced sporadic growing pains, but the long-term expectation for MJ is looking bright.

IBISWorld estimates that revenue for the CB production industry in Canada has increased an annualized 116.3% over the five years to 2020.

That Production Has Reached An Anticipated $3.5Bn In 2020!

I've been looking for a company looking to score its own piece of that anticipated $3.5Bn pie, and here's what I've come up with...

This new idea has been trending green the last few months and has started to gain some serious traction as a "Green Wave" company that is under-the radar, but one to watch closely.

Your new profile for Monday, August 10th is:

CannaPharmaRX, Inc. (CPMD)

CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to advance canna*binoid ("cannaBD") research and discovery using proprietary formulation and drug delivery technology currently in development.

As applications for cannaBD are brought to market across diverse industries such as cosmetics, health products, food and beverage, pet products, skin care, and pharmaceuticals, the collective market for C*B*D sales is expected to exceed $20Bn in the United States by 2024, according to BDS Analytics and Arcview Market Research.

Huge Market Potential - CPMD Could Be The Next Big Breakout

As the CB market continues to shine brightly and restrictions are letting up worldwide, CPMD could be the next Green Wave company to make a major statement.

A recent spate of press releases are painting a picture of a company moving in the right direction, but is still under-the-radar.

That said, it may not be for too long until this company's name makes a mainstream jump. Here's Why...

Your No. 1 Potential Catalyst For CPMD

Short-term technicals on CPMD couldn't be more attractive.

Barchart is reporting a "100% BUY" in the short-term as of 4:00PM EST Friday.

The website shares these short-term technical indicators as bullish:

  • 20 Day Moving Average
  • 20 - 50 Day MACD Oscillator
  • 20 - 100 Day MACD Oscillator
  • 20 - 200 Day MACD Oscillator

Need further proof of how hot CPMD has been? Look at its 3-month chart:


With this most recent leveling off around the $2.00 range, could CPMD be finding support for its next major run?

Since the beginning of July, CPMD has more than doubled in size. Why has that happened? Part of the reason has been all the major news the company has released this summer.


Your No. 2 Potential Catalyst For CPMD

CannaPharmaRx Agrees to Acquire CA CB Facility

Company Agrees to Purchase River Road Production Campus from Bristol Capital Investors

CALGARY, AB / ACCESSWIRE / July 7, 2020 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient CB production facilities in Canada, announced today it has signed a letter of intent to purchase a CB production facility located in Cathedral City, California.

The purchase price will be $10Mn. The acquisition is anticipated to close during the next 45 days, subject to CannapharmaRx receiving appropriate funding. The property will need approximately $20Mn in upgrades to become fully functional according to CannaPharmaRx's standards. While no assurances can be provided, the Company believes it has secured financing for this project via a senior credit facility. Upon completion of upgrades, which are expected to take approximately 6-7 months, the production facility is expected to generate up to 50,000 kilograms of CB per year.

"Completion of this acquisition will be a significant milestone for our Company. We are hopeful that it is the first of many transactions we are able to close this year in order to commence grow operations during the first half of next year," said Nick Colvin, CEO of CannaPharmaRx.


Your No. 3 Potential Catalyst For CPMD

CannaPharmaRx Announces its Plan to Move From the Pink Open Market to OTCQBCanna

PharmaRx Anticipates its Application Will be Submitted This Quarter

CALGARY, AB / ACCESSWIRE / June 16, 2020 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient CB production facilities in Canada, announced today that the Company has begun the process to move from the Pink Open Market to the OTCQB. The OTCQB Venture Market is for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process.

"We are excited for the possibility of advancing to the OTCQB from the Pink Open Market," said Nick Colvin, CEO of CannaPharmaRx. "We believe that this uplist will further validate our presence as a publicly traded company. We have already been following most of the criteria for OTCQB eligibility, but we look forward to formally being listed as an OTCQB company. While there are no assurances that OTCMarkets will approve our application, we are working diligently to ensure that we meet all of the necessary requirements for approval," added Colvin.


Your No. 4 Potential Catalyst For CPMD

CannaPharmaRx, Inc. Enters Revenue Growth Phase

CALGARY, AB / ACCESSWIRE / May 21, 2020 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient facilities for the distribution to wholesale licensed CB retailers, announced today that the Company has entered into a fundamental revenue growth phase via strategic acquisitions and end product opp's. The company is confident the strategy of acquiring complementary businesses and adding value will provide the most efficient path towards significant revenue generation.

Dominic Colvin, CEO of CannaPharmaRx stated, "There are many undervalued opp's that could benefit our business going forward. We believe we are entering a critical business phase that should enable material revenue growth for our company. Our plan is to continue to generate revenue through acquisition while simultaneously remaining active with the existing business within CannaPharmaRx. We remain confident with our growth forecast. Our commitment to become one of the top licensed producers in Canada remains our focus and we are excited to expand our vision as we increase revenues and continue acquisitions. The company looks forward to communicating with shareholders as materials events occur in the near term."


CPMD Is Strengthening Its Position In The Market Through A Variety Of Moves

  • In the process of completing an application to list its common stock on the Canadian Stock Exchange with initial trading anticipated to begin during the third quarter of 2020.
  • CPMD is working toward closing the acquisition of the Okanagan Falls project, a 760,000-square-foot glass house located on a 114-acre parcel in southern British Columbia, CA. Once fully built out, the facility has an annual production capacity of 265,000 pounds (120,000 kilograms). As a result of the current pandemic, like many other companies, CannaPharmaRx has experienced certain delays with closing the financing for this acquisition. The company believes those issues have been resolved and expect to close on this investment during the current quarter.
  • The company continues towards its goal of reviewing and researching multiple new acquisition and development opp's within the area of cultivation and genetics.
  • CPMD is fully expecting to file its annual report within the SEC's newly allotted time frames and intends to update shareholders periodically.


Pot Stocks Could Be In For A Major Second-Half 2020 Rebound

CannaPharmaRx Inc. may start getting recognized by Wall Street for its production facilities and plans in Canada.

According to BNN Bloomberg, for every 1 gram of CB priced at $10 in Canada, producers are estimated to earn $3.60. In addition, it is estimated that the private sector will generate close to $1Bn in EBITA with 85% coming from production and the rest from retail.

The loosening of government regulations has resulted in strong demand for the CB industry. In addition, the passing of the CB Act and CB 2.0 being rolled out in Canada have created a strong opp. for industry producers such as CannaPharmaRx, Inc.

CPMD could become one of Canada's biggest and most important companies in the CB market and is worth watching at current levels.

Coverage officially initiated on CPMD immediately.


Before Monday's opening bell, make sure to get CPMD on your radar.


Kai Parker


Source 1

Source 2

(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

Disclosure: I am not a lice.nsed finan.cial adviser. All potential percentage gains are based on from the low to the high of day. StockWireNews full disclosure is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading Stock Wire News email or text newsletter you are agreeing to StockWireNews full disclosure which can be read at Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com (“SCF”), an interest in the limited liability company that owns and operates fierce investor . com (“FI”), and an interest in the limited liability company that owns and operates stock street wire . com (SSW). From time to time, Stock Wire News, SCF, FI and/or SSW publicly disseminate information about a company via website, email, SMS and other points of media. (CORRECTION) Pursuant to an agreement between StockWireNews LLC and Electrik Dojo, LLC, StockWireNews was hired for a period beginning on 8/7/20 and ending on 8/10/20 to publicly disseminate information about (CPMD) via Website, Email and SMS. We were paid seventy-seven thousand five hundred USD via bank wire transfer. We own zero shares of (CPMD).